Farther Finance Advisors »

4d Molecular Therapeutics In shares owned by Farther Finance Advisors

Quarter-by-quarter ownership of 4d Molecular Therapeutics In (FDMT) shares owned by Farther Finance Advisors from 13F filings

Historical chart of Farther Finance Advisors investment in 4d Molecular Therapeutics In

Tip: Access up to 7 years of quarterly data

All positions including 4d Molecular Therapeutics In held by Farther Finance Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in 4d Molecular Therapeutics In by Farther Finance Advisors

Quarter filed Position value Share count Share price at filing
2024-09-30 $150 14 10.79
2024-06-30 $234 11 21.36
2024-03-31 $330 11 30.00
2023-12-31 $222 11 20.27

More positions owned by Farther Finance Advisors

Ishares Core S&p 500 Etf Etf (IVV)
Vanguard S&p 500 Etf Etf (VOO)
Nvidia Corporation Stock (NVDA)
Apple Stock (AAPL)
Ishares Core Total Usd Bond Market Etf Etf (IUSB)
Microsoft Corp Stock (MSFT)
Uva Unconstrained Medium-term Fixed Income Etf Etf (FFIU)
Ishares National Muni Bond Etf Etf (MUB)
Vanguard Ftse Developed Markets Etf Etf (VEA)
Vanguard Intermediate-term Bond Etf Etf (BIV)
Spdr S&p 500 Etf Trust Etf (SPY)
Ishares Msci Usa Quality Factor Etf Etf (QUAL)
Amazon Stock (AMZN)
Ishares Core S&p Small Cap Etf Etf (IJR)
Ishares S&p 500 Growth Etf Etf (IVW)

View all positions for Farther Finance Advisors

Top funds holding 4d Molecular Therapeutics In

BVF
RA Capital Management
BlackRock
VR Adviser
Deep Track Capital
Goldman Sachs Group
Henderson Group
Vanguard Group
State Street Corporation
Novo A/S
Redmile Group
Braidwell
Casdin Capital
Geode Capital Management
Polar Capital Holdings

View all funds holding 4d Molecular Therapeutics In